ACT-246475

DRUG3 trials

Sponsors

Viatris Innovation GmbH

Conditions

HealthyHealthy SubjectHealthy Subjects

Phase 1

A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy Subjects

CompletedNCT03430661

Viatris Innovation GmbHHealthy

Start: 2018-01-24End: 2019-05-29Updated: 2025-07-03

A Study to Evaluate ACT-246475 Fate in Healthy Male Subjects

CompletedNCT03593278

Viatris Innovation GmbHHealthy Subjects

Start: 2018-07-27End: 2018-08-05Updated: 2025-07-03

A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy Subjects

CompletedNCT03814200

Viatris Innovation GmbHHealthy Subject

Start: 2019-01-03End: 2019-02-19Updated: 2025-07-03